Linked Life Data

16474909

Source:http://linkedlifedata.com/resource/pubmed/id/16474909

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2006-3-15
pubmed:abstractText
[(18)]F Fluorodeoxyglucose-positron emission tomography (PET) scanning provides functional imaging based on glucose uptake by tumors. Melanoma is a glucose-avid malignancy, and preoperative PET scanning in melanoma patients has the potential to guide appropriate treatment.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
1068-9265
pubmed:author
pubmed:issnType
Print
pubmed:volume
13
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
525-32
pubmed:dateRevised
2007-7-18
pubmed:meshHeading
pubmed:year
2006
pubmed:articleTitle
Utility of preoperative [(18)]f fluorodeoxyglucose-positron emission tomography scanning in high-risk melanoma patients.
pubmed:affiliation
Department of Surgery, Memorial Sloan-Kettering Cancer Center, and Department of Surgery, Columbia University Medical Center, New York, New York 10021, USA. bradym@mskcc.org
pubmed:publicationType
Journal Article, Clinical Trial